Skip to main content
. 2020 Mar 10;11(3):290. doi: 10.3390/genes11030290

Table 4.

CLDN16 disease-causing variants [32].

Missense/Nonsense Mutations
Ref. Nucleotide Change Amino Acid Change Protein Change Variant Class Exon Domain
[84] c.114C>A Cys38Term p.C38 * DM a 1 N term
[78] c.211A>G Met71Val p.M71V DM 1 N term
[26] c.212T>G Met71Arg p.M71R DM 1 N term
[49] c.212T>C Met71Thr p.M71T DM 1 N term
[50] c.239G>A Cys80Tyr p.C80Y DM 1 TM1
[49] c.263G>A Gly88Glu p.G88E DM 1 TM1
[85] c.290A>G Asp97Gly p.D97G DM 1 ECS1
[53] c.295T>G Trp99Gly p.W99G DM 1 ECS1
[49,52] c.330C>G Ser110Arg b p.S110R DM 2 ECS1
[49,86] c.341G>A Arg114Gln p.R114Q DM 2 ECS1
[60] c.340C>T Arg114Term p.R114 * DM 2 ECS1
[56] c.346C>G Leu116Val p.L116V DM 2 ECS1
[45,66] c.350G>A Trp117Term p.W117 * DM 2 ECS1
[87] c.354G>A Trp118Term p.W118 * DM 2 ECS1
[52,88] c.358T>C Cys120Arg p.C120R DM 2 ECS1
[49] c.385C>T Arg129Cys p.R129C DM 2 ECS1
[50,54,64,71,86] c.416C>T Ala139Val p.A139V DM 2 ECS1
[45,49,66,86] c.421C>G His141Asp p.H141D DM 2 ECS1
[45,46,47,52,66,86] c.434T>C Leu145Pro p.L145P DM 3 ECS1
[86,89] c.446G>A Arg149Gln p.R149Q DM 3 ECS1
[45,46,86] c.446G>T Arg149Leu p.R149L DM 3 ECS1
[26,50] c.445C>T Arg149Term p.R149 * DM 3 ECS1
[45,46,47,49,52,66,86,88] c.453G>T Leu151Phe p.L151F DM 3 ECS1or TM2?
[45,49,66,86] c.452T>G Leu151Trp p.L151W DM 3 ECS1or TM2?
[50,54,71,86] c.485G>T Gly162Val p.G162V DM 3 TM2
[26,46] c.500T>C Leu167Pro p.L167P DM 3 TM2
[90] c.539C>T Pro180Leu p.P180L DM 3 ICL
[50,87,91] c.547A>G Lys183Glu p.K183E DM 3 ICL
[26,46,47,86] c.571G>A Gly191Arg p.G191R DM 3 TM3
[65] c.592G>C Gly198Arg p.G198R DM 3 TM3
[45,86] c.593G>C Gly198Ala p.G198A DM 4 TM3
[26,46,66,86] c.593G>A Gly198Asp p.G198D DM 4 TM3
[63] c.602G>A Gly201Glu p.G201E DM 4 TM3
[92] c.620G>A Trp207Term p.W207 * DM 4 ECS2
[45,46,47,49] c.625G>A Ala209Thr p.A209T DM 4 ECS2
[49,59,89] c.646C>T Arg216Cys p.R216C DM 4 ECS2
[55] c.647G>A Arg216His p.R216H DM 4 ECS2
[49,93] c.679G>C Gly227Arg p.G227R DM 4 ECS2
[26,46,47,94] c.695T>G Phe232Cys p.F232C DM 4 ECS2
[50] c.697G>C Gly233Arg p.G233R DM 4 ECS2
[26,46] c.698G>A Gly233Asp p.G233D DM 4 ECS2
[61] c.697G>T Gly233Cys p.G233C DM 4 ECS2
[52] c.702G>T Trp234Cys p.W234C DM 4 ECS2
[26] c.704C>T Ser235Phe p.S235F DM 4 ECS2
[45,46] c.703T>C Ser235Pro p.S235P DM 4 ECS2
[77] c.704C>A Ser235Tyr p.S235Y DM 4 ECS2
[49,95] c.710G>A Trp237Term p.W237 * DM 4 ECS2
[26,45,46,52,66,71,87] c.715G>A Gly239Arg p.G239R DM 4 ECL2 or TM4?
[52] c.734G>A Gly245Asp p.G245D DM 4 TM4
[82] c.823A>T c Lys275Term p.K275 * DM 5 C term
[81] c.831T>G d Tyr277Term p.Y277 * DM 5 C term
[52] c.864C>G Tyr288Term p.Y288 * DM 5 C term
[96] c.908C>G e Thr303Arg p.T303R DM 5 C term
Splicing Mutations
Ref. Nucleotide Change Splicing Mutation Variant Class
[45] c.325-5T>G IVS1 as T-G -5 DM
[60] c.427+5G>A IVS2 ds G-A +5 DM
[26] c.593-2A>G IVS3 as A-G -2 DM
[49,59] c.784+1G>T IVS4 ds G-T +1 DM
[45] c.785-14T>G IVS4 as T-G -14 DM
Small Deletions
Nucleotide Change Protein Change Variant Class Exon Domain
[97] c.166delG f p.(Ala56Leufs*16) DM? 1 N term
[49] c.235delG g p.(Ala79fsX90) 1 TM1
[45] c.368delA p.(Asn123Metfs*21) DM 2 ECS1
[49] c.408_410delCAT p.(Ile137del) DM 2 ECS1
[61] c.800delG p.(Arg267Lysfs*7) DM 5 C term
Small Insertions
Nucleotide Change Protein Change Variant Class Exon Domain
[74] c.324+3_324+4insT Not available DM intron 1
[71] c.545_548dupTTAA p.(Lys183Asnfs*2) DM 3 ICL
Small Indels
Nucleotide Change Protein Change Variant Class Exon Domain
[45,66] c.165_166delGGinsC p.(Arg55Serfs*17) R 1 N term
[45,46] c.646_647delCGinsAC p.(Arg216Thr) DM 4 ECS2
Gross Deletions
DNA Level Description Variant Class Exon Domain
[71,98] g.DNA Ex. 2-5 DM 2-5
Complex Mutations
Description Variant Class Exon Domain
[62] c.574_589delins23bp p.(A192Yfs∗ 25) DM 3 TM3

Variant class is described according the Human Gene Mutation Database [37] DM: Disease-causing mutations; DM?: probable/possible pathological mutation; «Retired records (R)», a variant that has been removed from HGMD if found to have been erroneously included ab initio or if the variant has been subject to retraction/correction in the literature resulting in the record becoming obsolete, merged or otherwise invalid. Domains are described according to authors and [99]. C Term, COOH terminus; TM, transmembrane domain; ECS1, first extracellular segment; ICL, intracellular loop; ECS2, second extracellular segment; N Term, NH2 terminus. a: the «significance» described by Trujillano was “likely pathogenic according to ACMG guidelines.” They categorized patients’ phenotypes according to the Human Phenotype Ontology nomenclature based on the clinical data and preceding workup provided by the referring physician. The phenotype described was: psychosis, seizures, muscle weakness, respiratory failure, reduced dihydropyrimidine dehydrogenase activity, decreased body weight, reduced consciousness/confusion, lower limb muscle weakness; b: reported as p.S110R 329AGC>AGG; c: reported as p.L203*, c.822A>T; d: reported as p.Y207*, c.620T>G; e: reported as p.T233R, c.697C>G; f: reported as c.164delG; g: reported as 236delG, p.A80fsX91,; * indicates that the predicted consequence is a termination codon.